Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 14.38x is in line with its 5-year average of 13.09x, around the middle of its 5-year range (7.94x–17.31x).
7.71% above its 12-month average of 13.35x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 10.24x.
INTEREST COVERAGE RATIO
14.38x
INTEREST COVERAGE RATIO AVG TTM
13.35x
INTEREST COVERAGE RATIO AVG 3Y
13.38x
INTEREST COVERAGE RATIO AVG 5Y
13.09x
INTEREST COVERAGE RATIO AVG 10Y
12.00x
INTEREST COVERAGE RATIO AVG 15Y
13.01x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.71%
CURRENT VS 3Y AVG
+7.45%
CURRENT VS 5Y AVG
+9.84%
CURRENT VS 10Y AVG
+19.85%
CURRENT VS 15Y AVG
+10.53%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.80x
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
+111.47%
vs the sector median at left
Novartis AG
Market Cap
$267.86B
Interest Coverage Ratio
14.38x
TTM Avg
13.35x
3Y Avg
13.38x
5Y Avg
13.09x
Market Cap
$243.50B
Interest Coverage Ratio
8.11x
TTM Avg
7.03x
3Y Avg
5.51x
5Y Avg
4.49x
Market Cap
$241.64B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$217.85B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$331.65B
Interest Coverage Ratio
14.34x
TTM Avg
11.95x
3Y Avg
16.17x
5Y Avg
26.28x
Market Cap
$336.29B
Interest Coverage Ratio
4.74x
TTM Avg
6.50x
3Y Avg
9.14x
5Y Avg
10.75x
Market Cap
$355.78B
Interest Coverage Ratio
17.31x
TTM Avg
16.61x
3Y Avg
13.70x
5Y Avg
12.98x
Market Cap
$179.35B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$168.48B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novartis AG (NVS) | $267.86B | 14.38x | 13.35x | 13.38x | 13.09x |
| AstraZeneca PLC (AZN)vs › | $243.50B | 8.11x | 7.03x | 5.51x | 4.49x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $241.64B | 5.71x | 5.17x | 6.77x | 10.10x |
| Amgen Inc. (AMGN)vs › | $217.85B | 3.88x | 3.09x | 3.93x | 4.89x |
| Roche Holding AG (RHHBY)vs › | $331.65B | 14.34x | 11.95x | 16.17x | 26.28x |
| UnitedHealth Group Incorporated (UNH)vs › | $336.29B | 4.74x | 6.50x | 9.14x | 10.75x |
| Merck & Co., Inc. (MRK)vs › | $355.78B | 17.31x | 16.61x | 13.70x | 12.98x |
| Gilead Sciences, Inc. (GILD)vs › | $179.35B | 11.43x | 6.56x | 7.26x | 7.18x |
| Abbott Laboratories (ABT)vs › | $168.48B | 23.60x | 17.46x | 17.67x | 16.77x |
| Novo Nordisk A/S (NVO)vs › | $165.95B | 30.34x | 54.30x | 123.94x | 139.58x |
Interest Coverage
14.4x
Debt/Equity
1.18
Current Ratio
0.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 10.24x |
| 2026-03-31 | 12.35x |
| 2025-12-31 | 11.58x |
| 2025-09-29 | 16.02x |
| 2025-06-30 | 16.56x |
| 2025-03-31 | 17.26x |
| 2024-12-31 | 12.93x |
| 2024-09-30 | 13.59x |
| 2024-06-30 | 16.34x |
| 2024-03-31 | 15.35x |
| 2023-12-31 | 10.81x |
| 2023-09-30 | 7.94x |
| 2023-06-30 | 13.00x |
| 2023-03-31 | 13.06x |
| 2022-12-31 | 8.07x |
| 2022-09-30 | 8.86x |
| 2022-06-30 | 11.03x |
| 2022-03-31 | 14.19x |
| 2021-12-31 | 12.44x |
| 2021-09-30 | 16.00x |
| 2021-06-30 | 17.31x |
| 2021-03-31 | 11.96x |
| 2020-12-31 | 13.15x |
| 2020-09-30 | 11.54x |
| 2020-06-30 | 10.69x |
| 2020-03-31 | 11.48x |
| 2019-12-31 | 8.93x |
| 2019-09-30 | 10.92x |
| 2019-06-30 | 12.99x |
| 2019-03-31 | 9.92x |
| 2018-12-31 | 5.24x |
| 2018-09-30 | 9.78x |
| 2018-06-30 | 10.26x |
| 2018-03-31 | 10.88x |
| 2017-12-31 | 9.95x |
| 2017-09-30 | 11.96x |
| 2017-06-30 | 11.88x |
| 2017-03-31 | 10.68x |
| 2016-12-31 | 8.66x |
| 2016-09-30 | 13.04x |
| 2016-06-30 | 11.63x |
| 2016-03-31 | 13.25x |
| 2015-12-31 | 13.52x |
| 2015-09-30 | 14.51x |
| 2015-06-30 | 13.91x |
| 2015-03-31 | 15.56x |
| 2014-12-31 | 15.27x |
| 2014-09-30 | 15.05x |
| 2014-06-30 | 19.18x |
| 2014-03-31 | 16.76x |
| 2013-12-31 | 14.56x |
| 2013-09-30 | 15.05x |
| 2013-06-30 | 17.33x |
| 2013-03-31 | 16.55x |
| 2012-12-31 | 12.47x |
| 2012-09-30 | 16.56x |
| 2012-06-30 | 16.98x |
| 2012-03-31 | 16.68x |
| 2011-12-31 | 7.57x |
| 2011-09-30 | 14.90x |
| 2011-06-30 | 17.48x |
| 2011-03-31 | 18.03x |
| 2010-12-31 | 12.59x |
| 2010-09-30 | 13.76x |
| 2010-06-30 | 16.92x |
| 2010-03-31 | 26.40x |
| 2009-12-31 | 16.90x |
| 2009-09-30 | 15.23x |
| 2009-06-30 | 17.38x |
| 2009-03-31 | 27.29x |
| 2008-09-30 | 24.32x |
| 2008-06-30 | 40.34x |
